Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir

NCT03631316 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation
Cytomegalovirus Infections
Pharmacokinetics
Therapeutic Equivalency

Interventions

DRUG: Generic Valganciclovir
DRUG: Innovative Valganciclovir

Sponsor

Luis Eduardo Morales Buenrostro